z-logo
open-access-imgOpen Access
Probiotic Potential of <b><i>Lactobacillus</i></b> Species in Allergic Rhinitis
Author(s) -
Nicole Charlotte Steiner,
Axel Lorentz
Publication year - 2021
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000515352
Subject(s) - probiotic , allergy , lactobacillus , immunology , medicine , asthma , immune system , cytokine , immunoglobulin e , microbiology and biotechnology , antibody , bacteria , biology , genetics
Since conventional allergy medication for asthma or allergic rhinitis (AR) can cause side effects which limit the patients’ quality of life, it is of interest to find other forms of therapy. In particular, probiotic bacteria, such as Lactobacillus species, have shown anti-allergic effects in various mouse and human studies. For instance, administration of some Lactobacillus species resulted in nasal and ocular symptom relief and improvement of quality of life in children and adults suffering from rhinitis. Different changes in cytokine profiles, such as elevated Th1 and decreased Th2 cytokines, reduced allergy-related immunoglobulins and cell immigration have been found in both human and murine studies. Positive effects on patients like less activity limitations or fewer rhinitis episodes and longer periods free from asthma or rhinitis were also described following oral administration of Lactobacillus bacteria. However, it is still unclear how this type of lactic acid bacteria leads to changes in the immune system and thus inhibits the development of allergies or relieves their symptoms. This review gives an overview of current studies and draws conclusions concerning the usage of probiotic Lactobacillus strains in AR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here